Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 1 Interventional

People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness

ClinicalTrials.gov ID: NCT07939529

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07939529. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 7:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This pilot, single-arm, open-label study conducted in the United States will evaluate the efficacy, safety, tolerability, and pharmacokinetics of long-acting lenacapavir plus cabotegravir (LA LEN+CAB) in people with HIV-1 viremia who have a history of non-adherence and confirmed or suspected rilpivirine (RPV) resistance. Participants will be on study for up to 108 weeks.

Study identification

NCT ID
NCT07939529
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 1
Enrollment
38 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2028 (Estimated)
Primary completion
Aug 31, 2029 (Estimated)
Completion
Oct 26, 2030 (Estimated)
Last update posted
Nov 16, 2026

2028 – 2030

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Alabama (Site ID: 31788) Birmingham Alabama 35222 —
University of California, Los Angeles CARE Center (Site ID: 601) Los Angeles California 90035 —
UCSD Antiviral Research Center (Site ID: 701) San Diego California 92103 —
University of California, San Francisco (Site ID: 801) San Francisco California 94110 —
Harbor University of California Los Angeles Center (Site ID: 603) Torrance California 90502-2052 —
University of Colorado Hospital (Site ID: 6101) Aurora Colorado 80045 —
Whitman-Walker Institute, Inc. (Site ID: 21791) Washington D.C. District of Columbia 20032 —
Northwestern University (Site ID: 2701) Chicago Illinois 60611 —
Johns Hopkins University (Site ID: 201) Baltimore Maryland 21287 —
Massachusetts General Hospital (Site ID: 101) Boston Massachusetts 02114 —
Brigham and Women's Hospital Therapeutics (BWH TCRS) (Site ID: 107) Boston Massachusetts 02115 —
New Jersey Medical School Clinical Research Center (Site ID: 31786) Newark New Jersey 07103 —
Weill Cornell Chelsea (Site ID: 7804) New York New York 10010 —
Weill Cornell Uptown (Site ID: 7803) New York New York 10010 —
Columbia Physicians & Surgeons (P&S) (Site ID: 30329) New York New York 10032 —
Chapel Hill (Site ID: 3201) Chapel Hill North Carolina 27599-7215 —
Greensboro (Site ID: 3203) Greensboro North Carolina 27401-1020 —
Cincinnati Clinical Research Site (Site ID: 2401) Cincinnati Ohio 45267-0405 —
Case Clinical Research Site (Site ID: 2501) Cleveland Ohio 44106 —
Ohio State University (Site ID: 2301) Columbus Ohio 43210 —
University of Pittsburgh (Site ID: 1001) Pittsburgh Pennsylvania 15213 —
Vanderbilt Therapeutics (VT) (Site ID: 3652) Nashville Tennessee 37204 —
Houston Advancing Research Team (Site ID: 31473) Houston Texas 77030 —
University of Washington Positive Research (Site ID: 1401) Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07939529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.